Bardzo tanie apteki z dostawą w całej Polsce kupic viagra i ogromny wybór pigułek.

Microsoft word - publikationsliste 2006-2011 für homepage.doc

PUBLIKATIONSLISTE 2011

1. Bäz I, Müller N, Beluchin E, Kloos C, Wolf G, Müller UA. Differences in the quality of
diabetes care caused by social inequalities in Germany disappear after treatment in a tertiary care center. Diabetic Medicine 28 (2011) 1-6 2. Blum M, Sämann A, Wolf G. The eye, the kidney and microcirculation. Nephrology, 3. Bondeva T, Wojciech S, Wolf G. Advanced glycation end-products inhibit adhesion ability of differentiated podocytes in a Neuropilin 1 dependent manner. Am J Physiol Renal 301 (2011) F852-F870 4. Doerr R, Hoffmann U, Otter W, Heinemann L, Hunger-Battefeld W, Kulzer B, Klinge A, Lodwig V, Amann-Zalan I, Sturm D, Tschoepe D, Spitzer SG, Stumpf J, Lohmann T, Schnell O. Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 54 (2011) 2923-2930 5. Franke S, Rüster C, Pester J, Hofmann G, Oelzner P, Wolf G. Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol 29 (2011): 650-660 6. Gerth J, Sachse A, Busch M, Illner N, Muegge LO, Gröne HJ, Wolf G. Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases. Kidney Blood Pressure Research 35 (2011) 120-128 7. Hansch A, Pfeil A, Neumann R, Neumann S, Mayer TE, Wolf G. Renal ablation in patients with end-stage renal disease. Vasa 40 (2011) 308-14 8. Hein G, Eidner T, Oelzner P, Rose M, Wilke A, Wolf G, Franke S. Influence of Rituximab on markers of bone remodeling inpatient with rheumatoid arthritis- a prospective open label pilot study. Rheumatol International 31 (2011)269-272 9. Hermann R, Ott U, Pfeil A, Maiwald J, Gajda M, Wolf G. Nephrogene systemische Fibrose: Verbesserung des Krankheitsverlaufs durch eine Nierentransplantation? Nieren- und Hochdruckkrankheiten (40)2011 29-34 10. Jung C, Pfeil A, Hamadanchi A, Hansch A. Cysts and trabecula. What is wrong with this liver? Polycystic degeneration of the liver and kidneys. MMW Fortschr Med 153 (2011) 5 11. Jung C, Pfeil A, Hansch A. An unusual finding in thoracic CT. MMW Fortschr Med 153 12. Kloos C, Müller N, Wolf G, Hartmann P, Lehmann T, Müller UA. Better HbA1c and blood pressure control in patients with diabetes mellitus treated at a primary health care level ten years after initiation of a diabetes qulaity improvement program. Exp Clin Endocrin & Diabetes 119 (2011) 459-462 13. Lehmann G, Pfeil A, Wolf G. Multiple Wirbelkörperfrakturen bei einer Primipara mit Hajdu-Cheney-Syndrom. Osteologie 4 (2011) 342-343 14. Lehmann G, Wolf G. Renale Osteodystrophie – Pathogenese, Diagnostik und Therapie. Medizinisch Orthopädische Technik 6 (2011) 46-53 15. Lehmann G, Wolf G. Skelettale Komplikationen bei chronischer Niereninsuffizienz und nach Nierentransplantation. Akt Rheumatol 36 (2011) 291-296 16. Lehmann G. Systemische Osteopathien in Pathologie des Bewegungsapparates. Veith Krenn, Wolfgang Rüther (Hrsg.) De Gruyter. 253-275 ISBN 978-3-11-022189-3 17. Loeffler I, Hopfer U, Koczan D, Wolf G. Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells. J Am Soc Nephrol 22 (2011) 649-663 18. Mah N, Wang Y, Liao MC, Prigione A, Jozefczuk J, Lichtner B, Wolfrum K, Haltmeier M, Flöttmann M, Schaefer M, Hahn A, Mrowka R, Klipp E, Andrade-Navarro MA, Adjaye J.
Molecular insights into reprogramming-initiation events mediated by the OSKM gene
regulatory network. PLoS One. 2011;6(8):e24351.
19. Müller N, Kloos C, Frank T, Ristow M, Wolf G, Müller UA. Prevalence of injection–meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes. Diabet Med 28 (2011) 223-226 20. Müller UA. The key to managing diabetes without tears – the treatment and teaching programme for flexible insulin therapy in Germany. Diabetes Voice 56 (2011) Special Issue 2, 16-18 http://www.idf.org/sites/default/files/attachments/DV_56-SI2.pdf 21. Müller UA. Werden DPP4-Hemmer Sulfonylharnstoffe in der Therapie des Typ-2- Diabetes ersetzen? Contra. Dtsch Med Wochenschr 136 (2011) 547 22. Neuman T, Wolf G. Nierenbeteiligung bei systemischen Vaskulitiden. Aktuelle 23. Neumann T, Sämann A, Lodes S, Kästner B, Franke S, Kiehntopf M, Hemmelmann C, Lehmann T, Müller UA, Hein G, Wolf G. Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabet Med 28 (2011) 872–875 24. Oelzner P, Wolf G. Nierenbeteiligung bei Kollagenosen. Aktuelle Rheumatologie 36 25. Ott U, Wolf G. Nierenbiopsie - die Rolle in der nephrologischen Diagnostik. Dialyse 26. Pfeil A, Betge S, Poehlmann G, Boettcher J, Drescher R, Malich A, Wolf G, Mentzel HJ, Hansch A. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium-An interrater reliability study. Eur J Radiol (2011) Epub ahead of print 27. Pfeil A, Busch M, Böttcher J, Hansch A, Freesmeyer M, Wolf G. Nichtinvasive bildgebende Verfahren - Technische Innovationen und Wertigkeit in der Nephrologie. Dialyse aktuell 15 (2011) 512-22 28. Pfeil A, Drobnik S, Rzanny R, Aboud A, Böttcher J, Schmidt P, Ortmann C, Mall G, Hekmat K, Brehm B, Reichenbach J, Mayer TE, Wolf G, Hansch A. Compatibility of temporary pacemaker myocardial pacing leads with magnetic resonance imaging: an ex vivo tissue study. Int J Cardiovasc Imaging (2011) Epub ahead of print 29. Pfeil A, Hansch A, Sommerfeld J, Fröber R, Renz DM, Lehmann G, Malich A, Wolf G, Böttcher J. Reproducibility and influence of hand rotation on computer-aided joint space analysis. Joint Bone Spine (2011) Epub ahead of print 30. Pfeil A, Haugeberg G, Hansch A, Renz DM, Lehmann G, Malich A, Wolf G, Böttcher J. Value of digital X-ray radiogrammetry in the assessment of inflammatory bone loss in rheumatoid arthritis. Arthritis Care Res (Hoboken) 63 (2011) 666-74 31. Pfeil A, Jung C, Boettcher J, Wolf G, Hansch A. Erdheim-Chester-Erkrankung – eine selten Erkrankung mit typischen Zeichen einer Knochenmanifestation. MMW Fortschr med 153 (2011) 24-25 32. Pfeil A, Jung C, Boettcher J, Wolf G, Hansch A. Which organs are involved here? Erdheim-Chester disease. MMW Fortschr Med 153 (2011) 5 33. Pfeil A, Sommerfeld J, Fröber R, Lehmann G, Malich A, Hansch A, Wolf G, Böttcher J. Feasibility study of semi-automated measurements of finger joint space widths. Rheumatol Int 31 (2011)1349-54 34. Renz DM, Röttgen R, Habedank D, Wagner M, Böttcher J, Pfeil A, Dietz R, Kivelitz D, Elgeti T. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. Rofo 183 (2011) 834-41 35. Ruester C, Franke S, Bondeva T, Wolf G. Erythropoetin protects podocytes from damage by advanced glycation end-products. Nephron: Experimental Nephrology 117 (2011) e21-e30 36. Ruester C, Franke S, Wenzel U, Schmidthaupt R, Fraune C, Krebs C, Wolf G. Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction. Am J Nephrol 34 (2011) 309-317 37. Ruester C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. Journal of the American Society of Nephrology 22 (2011) 1189-1199 38. Ruester C, Wolf G. Diabetische Nephropathie- Neues zur Pathogenese. Der 39. Schmidt P, Boettcher J, Ragoschke-Schumm J, Mentzel HJ, Wolf G, Müller UA, Kaiser WA, Mayer TE, Sämann A. Continuous monitoring of the human brain during severe insulin-induced hypoglycemia by diffusion-weighted MR imaging. Am J Neuroradiology 32 (2011)1321-1327 40. Wolf G, Busch M, Müller N, Müller UA. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary center. Nephrol Dial Transplant 26 (2011) 4017-4023 41. Wolf G, Witzke O. Nieren- und Diabeteserkrankungen. Der Nephrologe 6 (2011) 389 42. Wolf G. Journal Club: Entwicklung einer terminalen Niereninsuffizienz besser voraussagen? Dialyse aktuell 15 (2011) 492 43. Wolf G. The suffering of the Grail King in Wagner´s Parsifal: was it amyloidosis? Nieren- 44. Wolf G. Wie wirksam ist Aspirin bei Typ2-Diabetikern mit unterschiedlicher GFR? Diabetologie und Stoffwechsel 6 (2011) 148 45. Wolf G. Zum Thema: Diagnostik in der Nephrologie. Dialyse aktuell 15 (2011), 494 46. Zipfel PF, Wolf G, John U, Kentouche K, Skerka C. Novel Developments in Thrombotic Microangiopathies: Report From the 4th International Workshop on Thrombotic Microangiopathies. Pediatric Nephrology 26 (2011) 1947-1956 47. Zwerina J, Bach C, Martorana D, Jatzwauk M, Hegasy G, Moosig F, Bremer J, Wieczorek S, Moschen A, Tilg H, Neumann T, Spriewald B, Schett G and Vaglio A. Eotaxin-3 in Churg-Strauss Syndrome: A clinical and immunogenetic study. Rheumatology (Oxford) 50 (2011) 1823-7
PUBLIKATIONSLISTE 2010

1 Bahrmann A, Zieschang T,
Das Karpaltunnelsyndrom bei Diabetes mellitus. Med Klinik Neumann T, Hein G, Oster 105 (2010) 150-4
P.
2 Böttcher J, Pfeil A, Wolf G. Radiologische Progression bei rheumatoider Arthritis.
Evaluation mittels der Digitalen Radiogrammetrie. Orthopädie und Rheuma 6 (2010) 46-50 3 Busch M, Pfeil A, Traut M, Akutes Nierenversagen bei einer 70-jährigen Frau. Der
Romeike B, Wolf G.
4 Busch M, Göbert A,
Vitamin B 6 Metabolism in Chronic Kidney Disease – Franke S, Ott U, Gerth J,
Relation to Transsulfuration, Advanced Glycation and Müller A, Stein G, Bitsch R, Cardiovascular Disease; Nephron Clinical Practice 114
Wolf G.
5 Busch M, Franke S,
Advanced glycation end-products and the kidney; European Rüster Ch, Wolf G.
Journal of Clinical Investigation 40 (2010) 742–755 6 Eidner T.
Leitliniengerechte Osteoporose-Diagnostik: von der Risikostratifizierung zur Therapieentscheidung. DBI. Der Bay Int. 30 (2010) 120-125 7 Fischle EM, P.Oelzner,
Erst Hypokalzämie, dann Kalziummangel - Eine Expedition G.Hein, G.Wolf.
durch die Fallstricke des Kalziumstoffwechsel anhand eines Fallbeispiels. Nieren- und Hochdruckkrankheiten 39 (2010) 110-114 8 Fischle EM, Pfeil A,
Darstellung einer infizierten Gefäßprothese der Arteria iliaca Odparlik A, Neumann T,
mittels 18F-Fluorodeoxyglukose Ganzkörper - Positronenemissionstomographie Computertomographie bei Oelzner P, Freesmeyer M, einem Patienten nach Nierentransplantation. Nieren und
Wolf G.
9 Gerth J, Busch M, Illner N, Are tissue samples from two different anatomical areas of
Traut M, Gröne HJ, Wolf G. the kidney necessary for adequate diagnosis?; Clinical
10 Gerth J, Busch M, Ott U,
Verlauf einer Light Chain Deposition Disease (LCDD) über 8 Gröne HJ, Wolf G.
Jahre; Nieren- und Hochdruckkrankheiten 39 (2010) 338-343 11 Hallbauer J, Kreusch S,
Long-term Serum proteomes are quite similar under high- Kleem A, Wolf G, Rhode H. and low-flux hemodialysis treatment. Proteomics Clinical
12 Hansch A, Betge S, Pfeil A, Spontaneous rupture of the right coronary atery. Circulation
Mayer TE, Wolf G, Brehm
13 Hansch A, Neumann R,
Transarterial catheter embolization of a sarcoma for Gajda M, Marintchev I, Pfeil preoperative conditioning. Vasa 39 (2010) 185-188
A, Mayer TE.
14 Hasslacher C, Wolf G,
Diabetische Nephropathie-Praxis Leitlinie der DDG. Diabetologie und Stoffwechsel 5 (2010) 113-116 15 Häuser K, Ott U, Gerth J,
Einfluss des Urinvolumens auf die Progression einer Busch M, Stein G.
chronischen Nierenerkrankung; Nieren- und Hochdruckkrankheiten 39 (2010) 8-16 16 Hermann R, A Pfeil, M
Schwerste thrombotisch-thrombozytopenische Purpura Busch, C Kettner, D
(TTP) nach H1N1-Vakzinierung; Medizinische Klinik 105 La Rosée, G Wolf.
17 Hunger-Battefeld W,
Diagnostische Fallstricke beim Cushing-Syndrom. Internist Mandecka A, Gajda M,
Hansch A, Müller UA, Wolf
G.

18 Illner N, Wolf G.
Rituximab als effektive Therapie bei schwerster thrombotisch-thrombozytopenischer Purpura. Deutsche Med Wschr 135 (2010) 71-74 19 Kaemmerer D, Lehmann
Treatment of osteoporosis after liver transplantation with G, Wolf G, Settmacher U,
ibandronate. Transplant Int 23 (2010) 753-759 20 Kellner H, Bornholdt K,
Leflunomide in the treatment of patients with early rheumatoid-arthritis – results of a prospective non-interventional study. Clin Rheumatol 29 (2010) 913-20 21 Lehmann G, Wolf G.
Histomorphometrie des Knochens-Methode und Indikation. Der bayrische Internist 30 (2010) 136-140 22 Lehmann G, Wolf G.
Teriparatid-ein Überblick. Arzneimitteltherapie 28 (2010) 277-282 23 Marx C, Busch M, Ott U,
Sekundärer Hyperparathyreoidismus bei Patienten nach Nierentransplantation. Nieren und Hochdruckkrankheiten 93 (2010) 95-101 24 Marx C, Busch M, Ott U,
Proteinuria after conversion to sirolimus in kidney transplant Gerth J, Wolf G.
recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin receptor antagonists; Clinical Transplantation 24 (2010) 626–630 25 Oelzner P, Fleissner-
Combination therapy with dexamethasone and Richter S, Bräuer R, Hein
osteoprotegerin protects against arthritis-induced bone G, Wolf G, Neumann T.
alterations in antigen-induced arthritis of the rat. Inflamm Res 59 (2010)731-741 26 Ott U, Wolf G.
Indikation zur Nierenbiopsie nach Nierentransplantation. Der Nephrologe 6 (2010) 466-472 27 Ott U, Busch M, Steiner T, Presence of Cardiovascular Disease in Patients on a Waiting
List for Renal Transplantation and in Patients After Kidney Transplantation in a Single Center; Transplantation Proceedings 42 (2010) 3450–3454 28 Quick C, Kliem A, Berger
Gastric dysmotility in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb Juckel G, Yeragani VK, Bär 1;34(1):92-7 KJ. 29 Pfeil A, Neumann T,
Inflammatory Obstruction of the Ureter Caused by Infrarenal Römhild U, Fischle EM,
Aortitis. Circulation 121 (2010) 453-454 Odparlik A, Steiner G,
Mandecka A, Oelzner P,
Freesmeyer M, Wolf G.
30 Pfeil A, Pfeifer R, Böttcher
Cerebral hypoxia or cyanide intoxication? MMW Fortschr Schmidt P, Herzog A,
Kaiser WA, Wolf G, Hansch
A.
31 Pfeil A, Pfeifer R, Böttcher
Potential einer Differenzierung zwischen hypoxischer Hirnschädigung und Zyanidintoxikation in der MRT- und CT- Bildgebung des Gehirns. Münchner Medizinische Kaiser WA, Wolf G, Hansch Wochenschrift 43: (2010) 38-39
A.
32 Pfeil A, Reissig A, Heyne
Transthoracic sonography in comparison to multislice JP, Wolf G, Kaiser WA,
computed tomography in detection of peripheral pulmonary 33 Pfeil A, Schmidt P,
Parenchymal and pleural findings in pulmonary embolism Hermann R, Böttcher J,
visualized by multichannel detector computed tomography. Wolf G, Hansch A.
34 Ruester C, S.Franke,
Erythropoetin protects podocytes from damage by advanced T.Bondeva, G.Wolf.
glycation end-products. Nephron: Experimental Nephrology 117 (2011) e21-e30 35 Rüster C, Wolf G.
Models of diabetic nephropathy. Drug Discovery Today 7 (2010) 35-41 36 Schiel R, Kaps A, Kamer G, Wie erleben Kinder und Jugendliche mit Diabetes mellitus
Typ 1 und ihre Bezugspersonen Hypoglykämien? Müller UA
37 Stone MA, Wilkinson JC,
Evaluation and comparison of guidelines for the Charpentier G, Clochard N, management of people with type 2 diabetes from eight
Lindblad U, Müller UA,
European countries; Diabetes Res Clin Pract 87 (2010) 252- Nolan J, Rutten GE, Trento 60 M, Kamlesh Khunti K, on behalf of the GUIDANCE Study Group. 38 Thude, H, Weißenborn S,
No association between transmembrane protein-tyrosine in a Vilser C, Müller UA, Kloos German population. Hum Immunol 71 (2010) 220-3
C, Wolf G, Beck J, Barz D.
39 Wolf G, Amann K
Nierenbiopsie. Der Nephrologe 5 (2010) 463-465 40 Wolf G.
Darbopoetin: weniger kardiovaskuläre Komplikationen? Diabetologie und Stoffwechsel 3 (2010) 150 41 Wolf G.
Diabetische Nephropathie. Eine Langzeitkomplikation des Diabetes mellitus. Diabetes aktuell 2 (2010) 6-13 42 Wolf G.
Kann die stationäre Tätigkeit in der Nephrologie einem ärztlichen “burn-out” vorbeugen? Nieren- Hochdruckkrankheiten 93 (2010) 102-109 PUBLIKATIONSLISTE 2009

Bondeva T, Rüster C,
Advanced glycation end-products suppress neuropilin-1 Franke S, Hammerschmidt
expression in podocytes. Kidney Int 75 (2009) 605-616 E, Klagsbrun M, Cohen CD,
Wolf G
Bondeva T, Wolf G

Advanced glycation end-products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity. Am J Nephrol 30 (2009) 336-345 A structured treatment and teaching programme for older patients with diabetes mellitus--a prospective randomised controlled multi- Müller UA, Feucht I, Zeyfang centre trial. Age Ageing 38 (2009) 390-6
A. SGS
Long-term moderate intervention with n-3 long-chain PUFA- Hein G, Müller A, Eidner T,
supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br J Nutr 101 Factors Contributing to Terminal Digital Preference in 91398 Patients with Diabetes mellitus in Germany and Austria: Possible Müller UA, Holl RW
Impact on Therapeutic decisions. Diabet Med. 26 (2009) 947-8 Drinda S, Franke S, Eidner
Decreased RAGE expression in peripheral blood mononuclear T, Schmidt C, Rüster C,
cells of patients with rheumatoid arthritis. Clin Exp Rheumatol 27 Bondeva T, Hein G, Wolf G
Franck H, Braun J, Buttgereit Knochendichtemessungen bei entzündlich-rheumatischen
F, Demary W, Hein G,
Erkrankungen. Z. Rheumatol 68 (2009) 845-850 Franke S, Sommer M,
Advanced glycation end products induce cell cycle arrest and Rüster C, Bondeva T,
proinflammatory changes in osteoarthritic fibroblast-like synovial Marticke J, Hofmann G, Hein cells. Arthritis Res Ther 11 (2009) R136
G, Wolf G
Fünfstück R, Wolf G
Hypertonie bei Diabetes mellitus. Thüringer Ärzteblatt 20 (2009), 176-180 Gajda M, Schulze E, Reichelt Urine cytology after kidney transplantation. Lekarz Wojskowy 87
O, Wunderlich H, Gerth J,
Ott U, Junker K, Wolf G,
Katenkamp D
Gerth J, Busch M, Ott U,
Evolution of light chain deposition disease over 8 years. Clin Groene HJ, Wolf G
Gerth J, Busch M, Ott U,
Akutes Nierenversagen bei einer 36-jährigen Patientin mit Seifert M, Gröne HJ, Wolf G hebephrener Schizophrenie. Der Nephrologe 4 (2009) 148-151
Gerth J, Busch M, Oyen F,
Thrombotische Mikroangiopathie bei einem 17.jährigen Patienten: TTP, HUS oder etwas von beidem? Nieren- und Budde U, Groene HJ, Wolf
Gerth J, Schleussner E,
Pregnancy-associated thrombotic thrombocytopenic purpura Kentouche K, Busch M,
Seifert M, Wolf G
Gerth J, Wolf G

Physiologische Adaptationen während der normalen Schwangerschaft. Der Nephrologe 4 (2009) 301-305 Reduced Morg1 expression in ischemic human brain. Hammerschmidt E, Loeffler Morg1 heterozygous mice are protected from acute renal
I, Wolf G
ischemia-reperfusion injury. Am J Physiol Renal Physiol 297 (2009) F1273-F1287 Hansch A, Gajda M, Pfeil A,
Intracardiac metastases of hepatocellular carcinoma. Rofo 181 Hansch A, Neumann R, Pfeil Embolization of an unusual metastatic site of hepatocellular
A, Marintchev I, Pfleiderer S,
carcinoma in the humerus. World J Gastroenterol 15 (2009) 2280- Hansch A, Pfeil A, Rzanny
First-pass myocardial perfusion abnormalities in Churg-Strauss R, Neumann T, Kaiser WA
syndrome with cardiac involvement. Int J Cardiovasc Imaging 25 (2009) 501-510 Hasslacher C, Wolf G,
Diabetische Nephropathie. Diabetologie Stoffwechsel 4 (Suppl.2) Lack of type VIII collagen in mice ameliorates diabetic Schwesinger C, Löffler I,
nephropathy. Diabetes 58 (2009) 1672-1681 Fukai N, Olsen BJ, Stahl
RAK, Wolf G
Hunger-Battefeld W
Gestationsdiabetes – Eine häufige Schwangerschaftskomplikation: Diabetes aktuell (2009) 6: 272-276 Hunger-Battefeld W, Fath
Prevalence of polyglandular autoimmune syndrome in patients K, Mandecka A, Kiehntopf
with diabetes mellitus type 1. Med Klin 104 (2009) 183-91 M, Kloos C, Müller UA,
Wolf G
Hüter L, Simon TP,
Hydroxyethylstarch impairs renal function and induces interstitila proliferation, macrophage infiltration and tubular damage in an Reinhhart K, Wolf G,
isolated renal perfusion model. Crit Care 13 (2009) R23-R31 Illner N, Gerth J, Pfeiffer R,
Nearly a stairway to heaven”-severe dichromate intoxication in a Bruns T, Wolf G
young man. Clin Nephrol 71(2009) 338-341 Kloos C, Hagen F, Lindloh
Cognitive function is not associated with recurrent foot ulcers in C, Braun A, Leppert K,
patients with diabetes and neuropathy. Diabetes Care 32 (2009) Müller N, Wolf G, Müller UA 1355
Combined en bloc liver-pancreas transplantation in patients with liver cirrhosis and insulin-dependent type 2 diabetes mellitus. Müller U, Thrum K, Kloos C, Transplantation 87 (2009) 542-545
Wolf G
Krizanic F, Traut M, Gerth J, Case Report: a diabetic patient with acute renal failure and
Wolf G
cardiac hypertrophy. J Nephrol Renal Transplant 2 (2009) 54-65 Kunisch E, Jansen A, Kojima Prostaglandin E2 differentially modulates
F, Löffler I, Kapoor M, Kawai proinflammatory/prodestructive effects of TNF-a on synovial
S, Rubio I, Crofford LJ, and
fibroblasts via specific E prostanoid receptors/cAMP. J Immunol. Lehmann G, Ott U, Maiwald
Bone-histomorphometry after treatment with teriparatide (PTH 1- 34) in a patient with adynamic renal bone disease subsequent to parathyreodectomy. Nephro Dial Transplant Plus 2 (2009) 49-51 Lehmann G, Pfeil A,
Benefit of a 17 years long-term bisphosphonate therapy in a Böttcher J, Kaiser WA, Füller patient with Gorham Stout Syndrome. Archiv Othop Trauma
J, Hein G, Wolf G
Lehmann G, Wolf G
Biochemische Marker des Knochenumbaus bei Dialysepatienten. Nephrologie im Dialog 2 (2009) 9-12 Lehmann G, Wolf G
Renale Osteodystrophie: Knochenhistologie bei Niereninsuffizienz und nach Nierentransplantation. Osteologie forum 15 (2009) 26-29 Mandecka A, Dawczynski J,
Abnormal retinal autoregulation is detected by provoked Blum M, Vilser W, Kloos C,
stimulation with flicker light in well-controlled type 1 diabetes Müller N, Wolf G, Müller UA without retinopathy. Diab Res Clin Pract 86 (2009) 51-55
Materne C, Gerth J, Ott U,
Wechsel zwischen BK-Virus-Nephropathie und Abstoßung-der Gröne HJ, Wolf G
frustrane Verlauf einer Lebendnierenspende. Med Klinik 104 (2009) 644-648 Neumann T, Manger B, Kern Cardiac involvement in Churg-Strauss syndrome: impact of
P, Schmid M, Kroegel C,
endomycarditis. Medicine 88 (2009) 236-243 Hansch A, Kaiser WA,
Reinhardt D, Wolf G, Hein
G
, Mall G, Schett G, Zwerina
J
Neumann T, Oelzner P,
Diagnosis of large vessel vasculitis by [18F]fluorodeoxyglucose- positron emission tomography. Circulation 119 (2009) 338-339 Opfermann T, Hein G, Wolf
G
Ott U, Wolf G

Schwangerschaft bei Nierenersatztherapie und Nierentransplantation. Der Nephrologe 4 (2009) 326-333 Churg-strauss syndrome presenting with cardiac mass and right B, Oelzner P, Poerner TC
ventricular obstruction. Clin Cardiol 32 (2009) E77-79 Resolution of renal inflammation: a new role for NF-kB1 (p50) in inflammatory kidney disease. Am J Physiol:Renal 297 (2009) C, Meyer TN, Zahner G,
Gomez-Guerro C, Schmid
RM, Helmchen U, Moeckel
GW, Wolf G, Stahl RAK,
Thaiss F
The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 20 (2009) 969-979 Heymann F, Hölscher C,
Wolf G, Kurts C, Mittrücker
HW, Stahl RAK, Panzer U
Peupelmann J, Boettger MK, Cardio-respiratory coupling indicates suppression of vagal activity
Ruhland C, Berger S,
in acute schizophrenia. Schizophr Res 112 (2009) 153-157 Ramachandraiah CT,
Yeragani VK, Bär KJ
Pfeil A, Brehm B, Lopatta E,
Acute chest pain, heart failure and eosinophilia in a women Neumann T, Schmidt P,
without coronary disease. Cardiovasc Intervent Radiol 32 (2009) Wolf G, Kaiser WA, Hansch
A
Pfeil A
, Hansch A, Lehmann Impact of sex, age, body mass index and handedness on finger
G, Eidner T, Schäfer ML,
joint space width in patients with prologed rheumatoid arthritis Oelzner P, Renz DM, Wolf
using computer-aided joint space analysis. Rheumatol Int 29 G, Hein G, Kaiser WA,
Pfeil A, Lippold J, Eidner T,
Effects of leflunomide and methotrexate in rheumatoid arthritis Lehmann G, Oelzner P,
detected by digital X-ray radiogrammetry and computer-aided joint Renz DM, Hansch A, Wolf
space analysis. Rheumatol Int 29 (2009) 287-295 G, Hein G, Kaiser WA,
Böttcher J
Pfeil A, Schäfer ML,
Implementation of Z-scores as an age- and sex-independent Lehmann G, Seidl BE,
parameter for estimating joint space widths in rheumatoid arthritis. Eidner T, Malich A, Renz
DM, Oelzner P, Hansch A,
Wolf G, Hein G, Kaiser WA,
Böttcher J
TGF-b and fibrosis in different organs-molecular pathway imprints. Löffler I, Müller CK, Leipner
Biochim Biophys Acta 1792 (2009), 746-756 C, Schultze-Mosgau S,
Stallmach A, Kinne RW,
Wolf G
Preul C, Gerth J, Lang S,
Cerebral involvement in a case of Goodpasture syndrome due to shortened induction therapy: a acse report. J Med Case Reports 3 Wolf G, Terborg C
Rüster C, Bondeva T,
Angiotensin II upregulates RAGE expression on podocytes: role Franke S, Tanaka N,
of AT2 receptors. Am J Nephrol 29 (2009) 538-550 Yamamoto H, Wolf G
Sämann A, Lehmann T,
HbA1c-Kartographierung-Evaluation eines neuartigen Seelinger S, Kaiser J, Wolf
versorgungsepidemiologischen Verfahrens zum Monitoring der G, Müller UA
Stoffwechselkontrolle von Patienten mit Diabetes mellitus. Das Gesundheitswesen 71 (2009) 476-480 Die Behandlungsqualität von Patienten mit Typ-1- und Typ-2- Junghänel J, Müller UA
Diabetes mellitus in der hausärztlichen Betreuung: Ergebnisse einer vergleichenden Untersuchung in Ostvorpommern und Thüringen. Z Evid Fortbild Qual Gesundhwes 103 (2009) 453-60 Steiner T, Boehme C, Wolf
Impact of immunologic and non-immunologic variables on long- G, Schubert J, Ott U
term outcome after kidney transplantation. Transplant Proc 41 (2009) 2521-2523 Steiner T, Wunderlich H, Ott
Sexualität nach Nierentransplantation. Urologe 48 (2009) 1438- Temperature influence on DXA measurements: bone mineral Lehmann G, Fröber R,
density acquisition in frozen and thawed human femora. BMC Diabetes und Niere-Update 2009. Der Diabetologe 5 (2009) 190-199 Possible mythological meanings of kidney excision to Jack the Ripper. The Ripperologist 99 (2009) 1-7 Wolf G, Misselwitz J
Proteinurie und Progression von Nierenerkrankungen. PÄD Praktische Pädiatrie 15 (2009) 80-84 Wolf G, Müller N, Busch M,
Diabetic foot syndrome and renal function in type 1 and 2 Eidner G, Kloos C, Hunger-
diabetes mellitus show close association.Nephrol Dial Transplant Battefeld W, Müller UA
Wolf G, Ziyadeh F
Transforming growth factor-b and diabetic nephropathy. J Organ Dysfunction 5 (2009) 130-139 Wolf G, Schleussenr E
Schwangerschaft und Niere. Nephrologe 4 (2009) 299-300
PUBLIKATIONSLISTE 2008
A. Originalarbeiten 2008

Blum M, Kloos C, Günther S, Hunger-Battefeld W, Müller UA. Improved Metabolic
Control Results in Better Myogenic Response of Retinal Arterioles in Patients with
Diabetes Mellitus Type 1. Ophthalmologica 2008 222:373-377.
2. Bondeva
T, Scholl S, Liu Y, Clement JH, Höffken K, Wetzker R. Additive effects of
PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase gamma. J Cancer Res Clin Oncol. 2008 Aug;134(8):861-72. 3. Braun A, Oelzner P, Neumann T, Hein G, Gröne HJ, Ziemer M, Wolf G.
Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Rheumatol Int. 2008 Mar; 28(5):503-6. Braun A, Sämann A, Kubiak T, Zieschang T, Kloos Ch, Müller UA, Oster P, Wolf G,
Schiel R. Effects of metabolic control, patient education and initiation of insulin therapy
on the quality of life of patients with type 2 diabetes- mellitus. Running title: Impact of
diabetes treatment on quality of life. Patient Educ Consult. 2008 73, 50-59.
M, Franke S, Wolf G, Rohde RD, Stein G. Serum levels of the advanced
glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin II receptor type 1 blocker irbesartan in patients with type 2 diabetes and hypertension. Nephron Clin Pract. 2008; 108:c291-7. Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G. Behandlung der
idiopathischen membranösen Glomerulonephritis. Ist der Anti-CD20 Antikörper
Rituximab eine sinnvolle Therapieoption? Med Klinik 2008; 103: 519-24.
Gerth J, Busch M, Ott U, Seifert M, Traut M, Heyne J-P, Wolf G. Rechtsseitiger
Pleuraerguss bei einer jungen CAPD-Patientin. Nephrologe 2008; 3: 128-133.
Hartmann M, Gundermann C, Richter A, Eidner T, Hein G. Is the guideline,
„Management of early rheumatoid arthritis,“ being followed in a rheumatismcenter?
Dtsch Med Wochenschr. 2008; 35: 1721-4.
GE, Meister M, Oelzner P, Franke S. sRANKL and OPG in serum and synovial
fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis. Rheumatol Int. 2008 Jun;28(8):765-9. 10. Hunger-Battefeld
W, Wolf G. Lebenszeichen: Die Frau litt unter lebensbedrohlichen
Kaliummangel. Süddeutsche Zeitung Wissen 2008; 7/8: 43. 11. Kirchoff F, Krebs C, Abdulhag U, Meyer-Schwesinger C, Maas R, Helmchen U,
Hilgers K, Wolf G, Stahl R, Wenzel U. Rapid development of severe end-organ
damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kidney Int.
2008; 73:643-50.
12. Lange U, Oelzner P, Uhlemann C. Dercum`s disease (Lipomatosis dolorosa):
successful therapy with pregabalin and manual lymphatic drainage and a current overview. Rheumatol Int. 2008 Nov; 29(1):17-22. 13. Lehmann G, Ott U, Kämmerer D, Schütze J, Wolf G. Bone histomorphometry and
biochemical markers of bone turnover in patients with chronic kidney diseases stages 3-5. Clin Nephrol. 2008; 70:296-305. 14. Linde B, Hein G. DISH-Syndrom und Diabetes mellitus. Arthritis + rheuma 2008;
15. Lynemann JD, Frey O, Eidner T, Baier M, Roberts S, Sahihara J, Volkmer R, Cohen
JI, Hein G, Kamradt T, Münz C. Increased frequency of EBV-specific effector memory
CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;
181(2): 991-1000.
16. Mandecka
A, Dawczynski J, Blum M, Müller N, Kloos C, Wolf G, Vilser W, Hoyer H,
Müller UA. Influence of Flickering Light on the Retinal Vessels in Diabetic Patients:
Response to Nguyen, Cheung, and Wong. Diabetes Care 2008; 31(6): e52.
17. Müller
N, Schiel R, Osterbrink B, Holl RW, Kerner W, Hauner H, Beyer P, Hoyer H,
Krug J, Müller UA. Care and Outcome in Patients with Diabetes Mellitus Type 1 and
Type 2 in Specialized Practice, Diabetes Specialized Hospital and Diabetes
Department of a Regional General Hospital in Germany. Diabetologie 2008; 3: 41–50.
18. Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, Hein G.
Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int. 2008 Sep;28(11):1143–50. 19. Ott U, Busch M, Steiner M, Schubert J, Wolf G. Renal retransplantation: a
retrospective monocentric study. Transplant Proc. 2008; 40(5): 1345-1348. 20. Ott U, Busch M, Steiner T, Schubert J, Gröne E, Gröne HJ, Wolf G. Renal failure,
sepsis, and bilateral kidney tumors. Xanthogranulomatous Pyelonephritis. Kidney Int. 2008; 73(6): 787-788. 21. Ott U, Busch M, Steiner T, Wolf G. Anemia after renal transplantation – an
underestimated problem. Transplant Proc. 2008 Dec; 40(10): 3481-3484. 22. Ott U, Gerth J, Gröne HJ, Gröne E, Wolf G. Cholesterol embolization in a renal graft.
Clin Transplant. 2008 Sep-Oct; 22(5): 677-680. U, Steiner T, Busch M, Gerth J, Wolf G. A single-center experience with BK virus
nephropathy. Clin Nephrol. 2008; 69 (4): 244-250. 24. Panzer U, Zahner G, Wienberg U, Steinmetz OM, Peters A, Turner JE, Paust H, Wolf
G, Stahl RAK, Schneider A.15-deoxy-Δ12,14-prostglandin J2 inhibits INF-α-induced
SJAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in mesangial cells. Nephrol Dial Transplant. 2008; 23:3776-85. 25. Pfeil A, Böttcher J, Schäfer ML, Seidl BE, Schmidt M, Petrovitch A, Heyne JP,
Lehmann G, Oelzner P, Hein G, Wolf G, Kaiser WA. Normative reference values of
joint space width estimated by computer-aided joint space analysis (CAJSA): the distal
interphalangeal joint. J Digital Imaging 2008; 21:104-12 .
26. Polzer K, Karonitsch T, Neumann T, Eger G, Haberler C, Soleiman A, Hellmich B,
Csernok E, Distler J, Manger B, Redlich K, Schett G, Zwerina J. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity. Rheumatology (Oxford) 2008 Jun;47(6):804-8. 27. Rousseau JC, Sumer EU, Hein G, Sondergaard BC, Madsen S, Pedersen C,
Neumann T, Mueller A, Quist P, Delmas P, Karsdal MA. Patients with Rheumatoid
Arthritis have an altered circulatory Aggrecan Profile BMC Musculoskelet Disord. 2008
May 28;9(1):74.
28. Rüster C, Bondeva T, Franke S, Förster M, Wolf G. Advanced glycation end-
products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant. 2008 Jul;23(7):2179-91. 29. Sämann A , Tajiyeva O, Müller N, Tschauner T, Hoyer H, Wolf G, Müller UA.
Prevalence of diabetic foot syndrome at primary care level in Germany: a cross-sectional study. Diab Med. 2008; 25:557-63. 30. Sämann A, Lehmann T, Kloos C, Braun A, Hunger-Battefeld W, Wolf G, Müller
UA. Flexible, intensive insulin therapy and dietary freedom in adolescents and young
adults with Type 1 diabetes: a prospective implementation study. Diabet Med. 2008
May;25 (5):592-6.
31. Schäfer ML, Pfeil A, Renz DM, Lehmann G, Schmidt M, Hansch A, Hein G, Wolf G,
Kaiser WA, Böttcher J. Effects of long-term immobilisation on cortical bone mass after traumatic amputation of the phalanges estimated by digital X-ray radiogrammetry. Osteoporos Int. 2008; 19 (9), 1291-9. 32. Seifert M, Gerth J, Gajda M, Pester F, Pfeifer R, Wolf G. Eosinophilie – eine
differentialdiagnostische Herausforderung. Med Klin 2008; 103 (8): 591-597. 33. Siegmund R, Boer K, Pöschel K, Wolf G, Deufel T, Kiehntopf M. Comparison of the
ecarin chromogenic assay and different aPTTT assays for the measurements of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients. Throm Res 2008; 123:159-65. 34. Siegmund R, Boer K, Pöschel K, Wolf G, Deufel T, Kiehntopf M. Influence of direct
thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation and patients with liver dysfunction. Blood Coagul Fibrin 2008; 9:288-93. 35. Steiner T, Schubert J, Wolf G, Giessing M. 15. Jahrestagung des Arbeitskreises
Nierentransplantation der Akademie der Deutschen Urologen. Der Urologe 2008; 47:486-8. 36. Wernicke D, Voigt A, Müller A, Schmidt WA, Stiehl P, Hein G. Association between
histopathologic type II synovitis and increased amounts of pyridinoline in synovial tissue samples in rheumatoid arthritis. Z Rheumatol. 2008; 67 (3), 225-31. 37. Wolf G, Müller N, Hunger-Battefeld W, Kloos C, Müller UA. Hemoglobin
concentrations are closely linked to renal function in patients with type 1 and 2 diabetes mellitus. Kidney Blood Pressure Res. 2008; 31: 313-21. G. A kidney from hell?- A nephrological view of the Whitechapel murders in
1888. Nephrol Dial Transplant. 2008; 23:3343-9. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis. Nat Clin Nephrol. 2008; 4:474-5.
PUBLIKATIONSLISTE 2007
Orginalarbeiten

1. Bondeva
T, Roger T, Wolf G. Differential regulation of Toll-like receptor 4 gene
expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Am J Nephrol 2007 27: 308-314. 2. Böttcher J, Pfeil A, Kaiser WA, Hein G, Wolf G. New CAD techniques based on
digital hand radiographs for early diagnosis of rheumatoid arthritis. Hosp Imag Radiol 2007 2: 15-19. 3. Blum M, Kloos C, Mueller N, Mandecka A, Berner R, Bertram B, Mueller UA.
Prevalence of diabetic retinopathy: Check-up program of a public health insurance company in Germany 2002-2004. Ophthalmologe 2007 104 :499-500. 4. Busch M, Franke S, Stein G, Wolf G. Is the serum concentration of pentosidine a
predictor of cardiovascular events in patients with type 2 diabetes and kidney disease? Deutsche Medizinische Wochenschrift 2007 132: 1810-1814. 5. Dawczynski J, Mandecka A, Blum M, Müller UA, Ach T, Strobel J. Endothelial
Dysfunction of Central Retinal Vessels: A Prognostic Parameter for Diabetic Retinopathy? Klin Monatsbl Augenheilkd 2007 224 : 827-831. 6. Franke
S, Siggelkow H, Wolf G, Hein G. Advanced glycation endproducts influence
the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem 2007 113: 154-161. 7. Gerth J, Busch M, Oyen F, Schneppenheim R, Keller T, Budde U, Gröne HJ, Wolf
G. Thrombotic microangiopathy in a 17 year old patient: TTP, HUS, or a bit of both?
Clinical Nephrology 2007 68: 405-411.
J, Cohen CD, Hopfer U, Lindenmeyer MT, Sommer M, Gröne HJ, Wolf G.
Collagen type VIII expression in human diabetic nephropathy. Eur J Clin Invest 2007 37: 767-773. 9. Gerth J, Ott U, Busch M, Heyne JP, Baier M, Wolf G. Leistungsknick ein Jahr nach
Nierentransplantation-unspezifisches Symptom einer seltenen Infektion. Der Nephrologe 2007 2:124-127. 10. Harscher S, Rummler S, Oelzner P, Mentzel HJ, Brodhun M, Witte OW, Terborg C,
Isenmann S. Selective immunoabsorption in neurologic complications of systemic lupus erythematosus. Nervenarzt 2007 78: 441-444. 11. Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W, Wolf G,
Settmacher U. Prevention of Early loss of Bone Mineral Density After Liver Transplantation by Prostaglandin E1. Transplant Proc 2007 39:540-543. 12. Hunger-Dathe W, Hocke M, Sämann A, Müller UA, Wolf G, Gajda M. 64-jährige
Patientin mit rezidivierenden Hypoglykämien. Schwierige Diagnosestellung. Der Internist 2007 48:1020-1028. 13. Kloos Ch, Sämann A, Lehmann T, Braun A, Heckmann B, Müller UA. Flexible
intensive versus conventional insulin therapy in insulin-naive adults with type 2 diabetes: an open-label, randomized, controlled, crossover clinical trial of metabolic control and patient preference. Diabetes Care 2007 30 : 3031-3032. 14. Lehmann G, Becker K, Wolf G, Hein G. Schwere gemischte Osteopathie bei einer in
Deutschland lebenden Türkin. Akt Rheumatol 2007 32:49-51. 15. Lehmann G, Ott U, Stein G, Steiner T, Wolf G. Renal osteodystrophy after
successful renal transplantation-A histomorphometric analysis in 57 patients. Transplant Proc 2007 39: 3153-3158. 16. Linde B, Oelzner P, Katenkamp K, Hein G, Wolf G. Fulminantes Leberversagen bei
einer 39-jährigen Patientin mit Leukozytose, unklaren Fieberschüben und Arthralgien. Med Klinik 2007 102: 846-851. 17. Mandecka A, Dawczynski J, Blum M, Müller N, Kloos C, Wolf G, Vilser W, Hoyer H,
Müller UA. Influence of flickering light on the retinal vessels in diabetic patients.
Diabetes Care 2007 30 : 3048-3052
18. Materne C, Porubsky S, Gerth J, Gröne HJ, Wolf G. Histiocytosis X and renal
insufficiency. Nephrol Dial Transplant 2007 22: 3664-3667. 19. Müller A, Bölzner C, Eidner T, Smolenski UC, Hein GE. Factors modifying collagen
catabolism in patients with ankylosing spondylitis. Eur J Med Res 2007 12: 568-572. 20. Müller UA, Hunger-Dathe W, Müller N, Lodwig V, Langen L, Arnolds S und das
Advisory Board Insulinpumpentherapie für Erwachsene (2007). Langzeitglykämie und Hypoglykämien nach Teilnahme am strukturierten Behandlungs- und Schulungsprogramm „Insulinpumpen-Therapie für erwachsene Patienten mit Diabetes mellitus Typ 1” von Roche Diagnostics GmbH. Diabetologie und Stoffwechsel 2007 2:161–168. 21. Netzel M, Netzel G, Ott U, Bitsch I, Bitsch R, Frank T. Biological antioxidant activity of
a beverage containing polyphenols and ascorbic acid. Ernährung 2007 3: 102 – 109. 22. Oelzner P, Buttgereit F, Demary W, Franck H, Kern P, Hein G. The mechanism of
bone loss in rheumatoid arthritis: Description based on a case report. Z Rheumatol 2007 66: 337-340. 23. Oelzner P, Franke S, Lehmann G, Eidner T, Müller A, Wolf G, Hein G. Soluble
receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis-relationship with bone mineral density, disease activity and bone turnover. Clin Rheumatol 2007 26: 2127-2135. 24. Olsen AK, Sondergaard BC, Byrjalsen I, Tanko LB, Christiansen C, Müller A, Hein
GE, Karsdal MA, Qvist P. Anabolic and catabolic function of chondrocyte ex vivo is
reflected by the metabolic processing of type II collagen. OsteoArthritis and Cartilage
2007 15: 335-342.
25. Ott U, Aschoff A, Fünfstück R, Jirikowski G, Wolf G. DNA-fragmentation in acute and
chronic rejection after renal transplantation. Transplant Proc 2007 39: 73-77. 26. Ott U, Aschoff A, Pocok J, Fünfstück R, Jirikowski G, Stein G, Wolf G. DNA
fragmentation in chronic glomerulonephritis: an immunohistological analysis. Nephron Clinical Practice 2007 105: c18 – c28. 27. Pfeil A, Böttcher J, Seidl BE, Heyne JP, Petrovitch A, Eidner T, Mentzel HJ, Wolf G,
Hein G, Kaiser WA. Computer-aided joint space analysis of the metacarpal-
phalangeal and proximal-interphalangeal finger joint: normative age-related and
gender-specific data. Skeletal Radiol 2007 36: 853-864.
28. Pfeil A, Böttcher J, Seidl BE, Schäfer ML, Hansch A, Eidner T, Wolf G, Hein G,
Kaiser WA. Computer-Aided Joint Space Analysis (CAJSA) of the Proximal- Interphalangeal Joint-Normative Age-Related and Gender Specific Data. Acad Radiol 2007 14: 594-602. 29. Reichelt O, Pilchowski R, Müller J, von Eggeling F, Schubert J, Gröne HJ, Ott U,
Junker K. Identifizierung von Rejektionsmarkern nach Nierentransplantation mit Hilfe der Proteinchiptechnologie. Der Urologe A. 2007 46:1161 30. Renders L, Frisman M, Ufer M, Mosyagin I, Haenisch S, Ott U, Caliebe A, Dechant
M, Braun F, Kunzendorf U, Cascorbi I. CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients. Clin Pharmacol Ther 2007 81: 228 - 234. 31. Schiel R, Müller UA. Efficacy and Treatment Satisfaction of Once-daily Insulin
Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study. Exp Clin Endocrinol Diabetes 2007 115 : 627-633 32. Schweitzer D, Lasch A, van der Vorst S, Wildner K, Hammer M, Voigt U, Jutte M,
Muller UA. Change of retinal oxygen saturation in healthy subjects and in early
stages of diabetic retinopathy during breathing of 100% oxygen. Klin Monatsbl
Augenheilkd 2007 224: 402-410.
33. Schnell O, Heinemann L, Hunger-Dathe W, Kulzer B, Lodwig V, Klinge A, Sturm D.
Blutzuckermessung bei Typ-2-Diabetes ohne Insulintherapie: A never-ending Story. Diabetes, Stoffwechsel und Herz 2007 5: 345-346. 34. Sommer M, Wolf G. Rosiglitazone increasess PPAR γ in renal tubular epithelial cells
and protects against damage by hydrogen peroxide. Am J Nephrol 2007 27: 425-434. 35. Traut M, Haufe C, Eismann U, Deppisch R, Stein G, Wolf G. Increased binding of
ß2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced ß2-microglobulin concentrations: results of a cross-over study. Blood Purification 2007 25: 432-440. 36. Wolf G, Müller N, Mandecka A, Müller UA. Association of diabetic retinopathy and
renal function in patients with type 1 and 2 diabetes mellitus. Clinical Nephrol 2007 68: 81-86.
Übersichtsarbeiten

1. Hasslacher C, Kempe P, Ritz E, Wolf G. Praxisleitlinie-Diabetische Nephropathie.
Diabetol Stoffwechsel 2007 2(Suppl. 2): S159-S162. GE. Particular features of steroid-induced osteoporosis. Orthopäde 2007 36:

3. Hunger-Dathe
W. Gestationsdiabetes – Ein unterschätztes Problem für Mutter und
Kind im späteren Leben. MedReview 2007 6: 4-5. 4. Kleinwechter H, Bührer C, Hunger-Dathe W, Kainer F, Kautzky-Willer A, Pawlowski
B, Reiher H, Schäfer-Graf U, Sorger M. Praxisleitlinie DDG - Diabetes und Schwangerschaft. Diabetologie und Stoffwechsel 2007 2 (suppl 2): 1–7. 5. Lehmann G, Ott U, Mikolayzak F, Stein G, Schütze J, Wolf G. Evaluation der
Knochenmineraldichte bei Patienten mit renaler Osteodystrophie (ROD). Nieren- und U, Steiner T, Schubert J, Wolf G. Update Nephrologie: Nierentransplantation.
Medizinische Klinik 2007 102: 219 – 229. U, Werner T, Wolf G. Harnwegsinfektionen nach Nierentransplantation. Nieren-
und Hochdruckkrankheiten 2007 36: 489 - 495. 8. Rüster C, Wolf G. Pathophysiologie der diabetischen Nephropathie. Der Nephrologe
9. Rüster C, Wolf G. Update diabetische Nephropathie. Spektrum der Nephrologie
10. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J
11. Sämann A, Müller UA, Wolf G. Sicherheitsaspekte oraler Antidiabetika. Der
12. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic
nephropathy. Nephron Physiol 2007 106: 26-31.
PUBLIKATIONSLISTE 2006
ORIGINALARBEITEN

1. Oelzner P, Lehmann G, Eidner T, Franke S, Müller A, Wolf G, Hein G.
Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism. Rheumatol Int 2006, 26: 908-915. 2. Neumann
T, Oelzner P, Petrow PK, Thoss K, Hein G, Stein G.
Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis. Inflamm Res 2006, 55:32-39. 3. Rapp A, Grohmann G, Oelzner P, Uehleke B, Uhlemann C.
Does garlic influence rheologic properties and blood flow in progressive systemic sclerosis? Forsch Komplementarmed 2006, 13:141-146. 4. Drinda St, Oelzner P, Canet CC, Kaatz M, Wolf G, Hein G.
Fatal outcome of Pyoderma gangrenosum with multiple organ involvement and partially responding to Infliximab. CEJMed 2006, 1: 306–312. 5. Neumann
T, Bornkessel A, Pfleiderer SO, Hein G, Isenmann S, Wolf G, Terborg C.
Images in cardiovascular medicine. A swelling of the right neck and sudden death. Circulation 2006, 113:e768-769. M, Fleck C, Wolf G, Stein G.
Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease. Amino Acids 2006, 30: 225-232. M, Franke S, Wolf G, Brandstädt A, Gerth J, Ott U, Hunsicker LG, Stein G.
The advanced glycation end product (AGE) Nε-carboxymethyllysine (CML) is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Am J Kidn Dis 2006, 48: 571-579 8. Ulbricht
K, Bucha E, Poeschel KA, Stein G, Wolf G, Nowak G.
The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters. Clin Nephrol 2006 65: 180-90. 9. Ulbricht
K, Schmidt D, Ott U, Gerth J, Stein G, Wolf G.
Vergleich klinisch angewandter Clearancemethoden zur Einschätzung der Nierenfunktion bei Niereninsuffizienz. Nieren- und Hochdruckkrankheiten 2006, 35: 305-315. 10. Hunger-Dathe W, Mosebach N, Sämann A, Schulz J, Müller UA, Wolf G.
Prevalence of impaired glucose tolerance 6 years after gestational diabetes. Exp Clin Endocrinol Diabetes 2006; 114: 11-17. 11. Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller UA.
Flexible, intensive Insulintherapy in adults with type 1 Diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Diabetes Care 2006, 29: 2196-2199. 12. Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G,
Wolf G, Helmchen U, Schaerli P, Stahl RAK, Thaiss F.
Compartment specific expression and function of the chemokine IP 10/CXL10 in a
model of renal endothelial microvascular injury. J Am Soc Nephrol 2006, 17: 454-464.
13. Hopfer U, Hopfer H, Jablonski K, Stahl RAK, Wolf G.
The novel WD-repeat protein Morg1 acts as a molecular scaffold for HIF prolyl-hydroxylase 3 (PHD3). J Biol Chem 2006, 281: 8645-8655. 14. Böttcher J, Pfeil A, Rosholm A, Sörös P, Petrovitch A, Schaefer ML, Seidl BE, Malich
A, Hansch A, Wolf G, Kaiser WA.
Computerized quantification of joint space narrowing and periarticular
demineralization in patients with rheumatoid arthritis based on digital X-ray
radiogrammetry. Invest Radiol 2006, 41: 36-44.
15. Wolf G, Bohlender J, Roger T, Wenzel U.
Angiotensin II upregulates Toll-like receptor 4 on mesangial cells. J Am Soc Nephrol 2006, 17: 1585-1693. 16. Zahner G, Wolf G, Schroeder S, Stahl RAK.
Inhibition of platelet-derived growth factor induced mesangial cell proliferation by cyclooxygenase-2 overexpression is abolished through reactive oxygene species. FEBS Letters 2006, 580: 2523-2528. 17. Dreihaupt M, Ott U, Wolf G, Schubert J, Steiner T.
Realization of the sixth modification of guidelines for organ placement in renal transplantation-a single-center experience. Transplant Proceed 2006, 38: 682. 18. Wolf G, Müller N, Tschauner T, Müller UA.
Prävalenz von Nierenfunktionsstörungen im Diabetes TÜV der Deutschen BKK 2000 – 2004. Med Klinik 2006, 101: 441-447. 19. Rüster M, Sommer M, Stein G, Wolf G, Bauer K, Walter B, Bauer R.
Upregulation of renal angiotensin receptor type 1 and 2 expression in naturally occurring intrauterine growth restriction of newborn piglets. Cell Tissues Organs 2006, 182: 106-114. 20. von Öhsen J, Ott U, Frícke HJ, Wolf G.
Seltene Ursache einer Anämie bei einer nierentransplantierten Patientin. Med Klinik 2006, 101: 577-582 21. Böttcher J, Pfeil A, Rosholm A, Schäfer ML, Malich A, Petrovitch A, Seidel B,
Lehmann G, Mentzel HJ, Hein G, Wolf G, Kaiser WA.
Computerized digital imaging techniques provided by digital radiogrammetry as new
diagnostic tool in rheumatoid arthritis. J Digital Imaging 2006,19: 279-288.
22. Rüster C, Gerth J, Ott U, Pfeiffer R, Wolf G.
Visusverlust und akutes Nierenversagen bei einer 28jährigen Reiterin. Der Internist 2006, 47: 857-860. 23. Pfeil A, Böttcher J, Mentzel HJ, Lehmann G, Schäfer ML, Kramer A, Petrovitch A,
Seidl BE, Malich A, Hein G, Wolf G, Kaiser WA
Multi-site quantitative ultrasound compared to dual energy X-ray absorptiometry in
rheumatoid arthritis: effects of body mass index and inflamed soft tissue on
reproducibility. Rheumatol Int 2006, 26: 1084-1090.
24. Böttcher J, Pfeil A, Schäfer ML, Petrovitch A, Seidl BE, Menzel HJ, Lehmann G,
Malich A, Heyne JP, Hein G, Wolf G, Kaiser WA.
Normative data for digital X-ray radiogammetry from a female and male German
cohorts. J Clin Densitometry 2006, 9: 341-350.
25. Rüster M, Kiehntopf M, Gröne HJ, Wolf G.
A Friday afternoon case of apparent anti-glomerular basement nephritis. Nephrol Dial Transplant 2006, 21: 2328-2330. 26. Wenzel U, Stahl R, Adam G, Wolf G.
Schwellung des Shuntarms bei einem Dialysepatienten. Der Nephrologe 2006, 1: 103-105. 27. Wolf G.
Portrayal of negative qualities in a doctor as a potential teaching tool in medical ethics and humanism: “Journey to the End of Night” by Louis-Ferdinand Céline. Postgraduate Medical J 2006, 82: 154-156. 28. Böttcher J, Pfeil A, Petrovitch A, Schmidt M, Kramer A, Schäfer ML, Gajda M, Hein
G, Wolf G, Kaiser WA.
Metacarpal index estimated by digital X-ray radiogrammetry as a tool for
differentiating rheumatoid arthritis related periarticular osteopenia. Int J Biomed
Science 2006, 2: 241-245.
29. Lehmann G, Stein A, Müller A, Hein G, Stein G, Wolf G.
Vitamin K-Serumspiegel bei Patienten mit renaler Osteodystrophie. Nieren- und Hochdruckkrankheiten 2006, 35: 448-453. 30. Schiekofer S, Franke S, Andrassy M, Chen J, Rudowsky G, Schneider JG, von
Eynatten M, Wendt T, Morcos M,Kientsch-Engel R, Stein G, Schleicher E, Nawroth PP, Bierhaus A. Postprandial mononuclear NF-kappa B activation is independent of the AGE-content of a single meal. Exp Clin Endocrinol Diabetes 2006, 14: 160-167. 31. Dawczynski J, Vater C, Kasper M, Franke S, Augsten R, Jurkutat S, Strobel J,
Königsdörffer E. Advanced glycation end products and pseudoexfoliation - correlation between clinical outcome and histological findings. Klin Monatsbl Augenheilkd 2006, 223: 748-751 32. Dawczynski J, Janz S, Kasper M, Franke S, Königsdörffer E, Augsten R, Strobel J.
Histological and immunohistological investigations in human epiretinal membranes. Klin Monatsbl Augenheilkd 2006, 223: 687-690 33. Mentzel HJ, Blume J, Boettcher J, Lehmann G, Tucjscherer D, Pfeil A, Kramer A,
Malich A, Kauf E, Hein G, Kaiser WA.
The potential of digital X-ray radio-grammetry (DXR) in the assessment of osteopenia
in children with chronic inflammatory bowel disease. Pediatr Radiol 2006, 36: 415-
420.
34. Blum M, Pils C, Müller UA, Strobel J.
The myogenic response of retinal arterioles in diabetic retinopathy. Ophthalmologe 2006, 103:209-13. 35. Gensischen J, Muth C, Butzlaff M, Rosemann T, Raspe H, Müller de Comejo G,
Beyer M, Härter M, Müller UA, Angermann CE, Gerlach FM, Wagner ED.
Die Zukunft ist chronisch: das Chronic Care-Modell in der deutschen
Primärversorgung. Übergreifende Behandlungsprinzipien einer proaktiven
Versorgung für chronische Kranke. Z ärztl Fortbild Qual Gesundh wes 2006, 100:
365-374.
36. Schiel R, Müller UA, Beltschikow W, Stein G.
Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial. J Diabetes Complications 2006, 20: 273-279. 37. Schiel R, Voigt U, Ross IS, Braun A, Rillig A, Hunger-Dathe W, Stein G, Muller U
A.
Structured Diabetes Therapy and Education Improves the Outcome of Patients with
Insulin Treated Diabetes Mellitus - The 10 Year Follow-Up of a Prospective,
Population-Based Survey on the Quality of Diabetes Care (The JEVIN Trial). Exp Clin
Endocrinol Diabetes 2006, 114: 18-27.
38. Reichelt O, Müller J, von Eggeling F, Driesch D, Wunderlich H, Schubert J, Gröne HJ,
Stein G, Ott U, Junker K.
Prediction of renal allograft rejection by urinary protein analysis using ProteinChip
Arrays (surface-enhanced laser desorption/ionization time-of-flight mass
spectrometry). Urology 2006, 67:472-5.
39. Keller T, Lehmann G, Sperschneider H.
Effekt des Bisphosphonats Ibandronat bei der Behandlung der Osteoporose nach Nierentransplantation. Nieren- und Hochdruckkrankheiten 2006, 35:1-9. ÜBERSICHTSARBEITEN
1. Hunger-Dathe W, Wolf G.
Albuminurie beim Diabetes mellitus - Marker und Motor der diabetischen Nephropathie und vaskulärer Komplikationen. Der Diabetologe 2006, 2: 400-409. 2. Gerth J, Ott U, Busch M, Poeschl K, Kroegel CC, Heyne JP, Wolf G.
Therapierefraktäre pulmonale Infiltrate nach Nierentransplantation. Der Nephrologe 2006, 1: 56-58. Niereninsuffizienz und Schwangerschaft, Teil 1. Diatra 2006, 2: 14-19. Niereninsuffizienz und Schwangerschaft, Teil 2. Diatra 2006, 3: 15-18. 5. Panzer U, Steinmetz O, Stahl RAK, Wolf G.
Kidney diseases and chemokines. Current Drug Targets 2006, 7: 65-80. Are oral contraceptives associated with increased renin-angiotensin activity and risk of nephropathy in diabetic women? Nature Clinical Practice Nephrology 2006, 2: 78-79. 7. Ott U, Wolf G.
Posttransplantationsdiabetes-Achillesferse der Transplantationsmedizin? NephroNews 2006, 8: 1-5. Neue Aspekte der Hochdrucktherapie bei diabetischer Nephropathie. Med Report 2006, 30: 6. Antihypertensiva und Niere-Pleiotrope Wirkungen. Diabetes News 2006, 5: 12. 10. Wolf G.
Prophylaxe und Therapie der diabetischen Nephropathie. Nephrologie im Dialog 2006, 2: 4-8. 11. Hunger-Dathe W, Wolf G, Müller UA.
Betreuung von Frauen mit Diabetes mellitus Typ 1 und Typ 2 präkonzeptionell und während der Schwangerschaft. Diabetes aktuell für die Hausarztpraxis 2006, 4: 7-10. 12. Wolf G.
Zeit als vernachlässigte Krankheitsdimension: Patienten mit chronischer Niereninsuffizienz als Beispiel. Nieren- und Hochdruckkrankheiten 2006, 35: 185-190. 13. Hunger-Dathe W, Wolf G, Müller UA.
Gestationsdiabetes-eine häufige Schwangerschaftskomplikation. Diabetes aktuell für die Hausarztpraxis 2006, 4: 11-16. 14. Rüster C, Wolf G.
The renin-angiotensin-aldosterone-system and progression of renal disease. J Am Soc Nephrol 2006, 17: 2985-2991. 15. Pöschel KA, Wolf G.
Diabetiker an der Dialyse. Diabetes, Stoffwechsel und Herz 2006, 15: 67-76. 16. Schubert J, Dreikorn K, Seiter H, Huland H, Jonas D, Kälble T, Wolf G, Steiner Th.
Nierentransplantation in der Urologie: Vergangenheit-Gegenwart-Zukunft. Der Urologe 2006, 45: 85-89. 17. Wolf G.
Renal injury due to renin-angiotensin-aldosterone system activation of the TGF-ß pathway. Kidney Int 2006, 70: 1914-1919. 18. Pöschel KA, Wolf G.
Das Renin-Angiotensin-Aldosterone System als zentraler Mediator der Progression der Niereninsuffizienz. Der Nephrologe 2006, 1: 233-240. 19. Hein G, Weiss C, Lehmann G, Niwa T, Stein G, Franke S,
Advanced glycation endproduct (AGE)-modification of bone proteins and bone remodelling - hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 2006, 65: 101-104. 20. Dreher R, Buttgereit F, Demary W, Görtz B, Hein G, Kern P, Schulz A,
Insuffizienzfrakturen in der Rheumatologie - Fallbeschreibung und Übersicht. Z Rheumatol 2006, 65:417-424. 21. Hein G.
Glycation endproducts in osteoporosis - is there a pathophysiologic importance? Clinica Chimica Acta 2006, 371: 32-36. 22. Lehmann G, Hein G, Wolf G.
Der niereninsuffiziente Osteoporosepatient: Was ist bei der osteoprotektiven Medikation zu beachten? Z Rheumatol 2006, 65:378-382. 23. Kaiser R, Kaatz M, Oelzner P.
Lyme-Borreliose - Klinik und Therapie. Ärtzebl Thüring 2006, 17:263ff 24. Fünfstück R, Ott U, Naber KG.
The interaction of urinary tract infection and renal insufficiency. Intern J Antimicrob Agents 2006, 28: 71-77.

Source: http://www.kim3.uniklinikum-jena.de/kim3_media/-p-426.pdf?rewrite_engine=id

Untitled

Effects of rimonabant on behavior maintained by progressiveratio schedules of sucrose reinforcement in obeseZucker (fa/fa) ratsErin B. Rasmussen and Sally L. HuskinsonThis experiment reports on the ability of rimonabant to alterfindings extend the literature that rimonabant reduces foodthe reinforcing properties of food in the genetically obesereinforcer efficacy, and suggest that obese Zucker

Microsoft word - montes et al.doc

EFFECT OF TEMPERATURE ON THE ENCAPSULATION OF AMOXICILLIN MICROPARTICLES BY SAS PROCESS A. Montes (*); M. D. Gordillo; C. Pereyra and E. J. Martínez de la Ossa Department of Chemical Engineering and Food Technology, Faculty of Sciences, University of Cádiz Phone: +34-956-016-458. Fax: +34-956-016-411 Drug encapsulation processes has been an active field of research and innovation du

Copyright © 2010-2014 Medical Articles